Lupin Ltd. secured USFDA approval for its generic risperidone...

ALNY's Amvuttra revenues surge with 89% sales growth in H1 and a key label expansion, but faces tough competition in the ATTR-CM market.

"Obesity Market Insight, Epidemiology and Market Forecast report" DelveInsight Business Research's latest report highlights the transformative impact...

For the first time in decades, residents of Newbern, Alabama, went to the polls, and they delivered a resounding victory to Patrick Braxton, the...

For the first time in decades, residents of Newbern, Alabama, went to the polls, and they delivered a resounding victory to Patrick Braxton, the...

(Reuters) -The NFL views international games as a key catalyst in its push to become a "true global sport property" and will hold a record seven...

MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.

MBOT's new U.S. patent boosts the LIBERTY system's flexibility, expanding its U.S. market reach to over six million annual procedures.

With global drugs worth over $250 billion going off─patent by 2030, a great opportunity awaits Indian pharma, but one that comes with intense...

With global drugs worth over $250 billion going off─patent by 2030, a great opportunity awaits Indian pharma, but one that comes with intense...